Literature DB >> 21805034

Non-small cell lung cancer invasion and metastasis promoted by MMP-26.

Yang Zhang1, Hang Zhao, Yeling Wang, Yong Lin, Yan Tan, Xuexun Fang, Lianwen Zheng.   

Abstract

Matrix metalloproteinase 26 (MMP-26) is a novel member of the matrix metalloproteinase (MMP) family and is widely expressed in cancer cells of epithelial origin. MMP-26 has been shown to contribute to tumor development and to the restoration of tissue injury. In this study, in order to identify the functions of MMP-26 that contribute to the biological phenotype and behavior of human lung carcinoma A549 cells, we established an MMP-26 low-expressing tumor cell model using RNA interference (RNAi) transfection. These cells were used to investigate the role of MMP-26 in tumor progression. The MTT, colony forming, adhere-nce and spreading, wound-healing and Transwell chamber invasion assays were performed to analyze the invasion ability of pshRNA-MMP26-transfected A549 cells. Semi-quantitative reverse transcription polymerase chain reaction, Western blotting and double immunofluorescent staining were employed to detect the relationship between MMP-26 and MMP-9. Results showed that the adhesive rate was down-regulated in pshRNA-MMP26-transfected cells, compared to the controls. Silencing of the MMP-26 gene significantly retarded the invasiveness of A549 cells in Transwell insert invasion assays. The cells proliferated in the three-dimensional (3D) culture system. A549 cells transfected with the pshRNA-MMP26-C plasmid mainly developed reticular structures in morphology, and formed few clones with clear and smooth edges as well as tight intercellular junctions. The mRNA and protein expression of MMP-9 in pshRNA-MMP26-transfected cells were significantly lower than those of the controls. Double immunofluorescence labeling and focal laser scanning microscopy showed that MMP-26 was colocalized with MMP-9 in the controls. In conclusion, we successfully established an MMP-26 low-expressing cell model and confirmed that MMP-26 contributed to A549 cell invasion and migration in vitro. We also demonstrated that MMP-26 plays an important role in local invasion at least in part through coordination with MMP-9.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21805034     DOI: 10.3892/mmr.2011.540

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  9 in total

1.  Regulation of chondrosarcoma invasion by MMP26.

Authors:  Xiaoshan Xu; Jinxing Ma; Chunxiao Li; Wanqiu Zhao; Yongqing Xu
Journal:  Tumour Biol       Date:  2014-09-28

2.  Activation of FGF receptor signaling promotes invasion of non-small-cell lung cancer.

Authors:  Deping Zhao; Yi Lu; Chenlu Yang; Xiao Zhou; Zhifei Xu
Journal:  Tumour Biol       Date:  2015-01-08

3.  MMP26: A potential biomarker for prostate cancer.

Authors:  Teng Cheng; Fei Li; Rui Wei; Meng-Qin Lv; Yin Zhou; Yun Dai; Yuan Yuan; Gui-Ying Jiang; Ding Ma; Qing-Lei Gao
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2017-12-21

Review 4.  Matrix Metalloproteinases and Their Inhibitors in Pulmonary Fibrosis: EMMPRIN/CD147 Comes into Play.

Authors:  Lourdes Chuliá-Peris; Cristina Carreres-Rey; Marta Gabasa; Jordi Alcaraz; Julián Carretero; Javier Pereda
Journal:  Int J Mol Sci       Date:  2022-06-21       Impact factor: 6.208

5.  Inhibition of fibroblast growth factor receptor signaling impairs metastasis of hepatocellular carcinoma.

Authors:  Jiajun Wang; Hongying Su; Xiangjun Han; Ke Xu
Journal:  Tumour Biol       Date:  2014-08-05

6.  Roles of matrix metalloproteinase-26 in the growth, invasion and angiogenesis of breast cancer.

Authors:  Hongfa Yang; Yang Wang; Yilei Li; Lihong Zhang; Yiping Deng; Dongxue Qi; Yulin Li; Wei Li
Journal:  Oncol Lett       Date:  2012-07-27       Impact factor: 2.967

7.  Systems biology approach to stage-wise characterization of epigenetic genes in lung adenocarcinoma.

Authors:  Meeta P Pradhan; Akshay Desai; Mathew J Palakal
Journal:  BMC Syst Biol       Date:  2013-12-26

8.  MiR-125b regulates endometrial receptivity by targeting MMP26 in women undergoing IVF-ET with elevated progesterone on HCG priming day.

Authors:  Cheng Chen; Yue Zhao; Yang Yu; Rong Li; Jie Qiao
Journal:  Sci Rep       Date:  2016-05-04       Impact factor: 4.379

9.  A Genome-Wide Profiling of Glioma Patients with an IDH1 Mutation Using the Catalogue of Somatic Mutations in Cancer Database.

Authors:  Amrit L Pappula; Shayaan Rasheed; Golrokh Mirzaei; Ruben C Petreaca; Renee A Bouley
Journal:  Cancers (Basel)       Date:  2021-08-26       Impact factor: 6.639

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.